{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T17:08:38Z","timestamp":1789232918547,"version":"build-2803163510"},"reference-count":182,"publisher":"Oxford University Press (OUP)","issue":"9","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,9,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>To summarize recent advances in nanotechnology-based topical drug delivery systems for atopic dermatitis (AD) and highlight their potential to overcome the limitations of conventional topical therapies, particularly poor skin penetration, adverse effects, and inadequate drug concentrations in deeper skin layers.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>The current literature on nanocarrier-based drug delivery for AD was reviewed, with emphasis on liposomes, ethosomes, transferosomes, solid lipid nanoparticles, nanostructured lipid carriers, polymeric nanoparticles, nanoemulsions, cubosomes, micelles, and metal\u2013organic frameworks. Emerging approaches involving the gut\u2013skin axis and microbiome-modulating strategies, including probiotics and postbiotics, were also considered.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Key findings<\/jats:title>\n                    <jats:p>AD is a chronic, relapsing inflammatory skin disease marked by intense pruritus, impaired epidermal barrier function, and immune dysregulation. It affects nearly 20% of children and 3%\u201310% of adults globally, imposing a significant clinical and socioeconomic burden. Current treatment mainly relies on topical therapies; however, their effectiveness is often limited by poor penetration through the stratum corneum. Prolonged use of conventional topical agents is also associated with adverse effects, which may reduce patient adherence and long-term therapeutic success. Nanocarrier systems offer promising solutions by enhancing skin permeability, enabling controlled and targeted drug delivery, and reducing systemic exposure. Emerging evidence also supports combining nanocarrier-based delivery with microbiome-modulating approaches.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Nanotechnology-based delivery systems show considerable potential for improving topical treatment outcomes in AD. However, despite encouraging preclinical results, clinical translation requires standardized manufacturing, detailed safety evaluation, and well-designed clinical trials.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/jpp\/rgag100","type":"journal-article","created":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T11:15:44Z","timestamp":1786965344000},"source":"Crossref","is-referenced-by-count":0,"title":["Beyond the skin barrier: nanocarrier-based drug delivery with emerging insights into the gut\u2013skin axis and probiotic modulation in atopic dermatitis"],"prefix":"10.1093","volume":"78","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-6352-0535","authenticated-orcid":false,"given":"Rohit","family":"Sharma","sequence":"first","affiliation":[{"name":"Chitkara College of Pharmacy, Chitkara University , Rajpura, Punjab 140401 ,","place":["India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2979-1590","authenticated-orcid":false,"given":"Thakur Gurjeet","family":"Singh","sequence":"additional","affiliation":[{"name":"Chitkara College of Pharmacy, Chitkara University , Rajpura, Punjab 140401 ,","place":["India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6659-4751","authenticated-orcid":false,"given":"Ashutosh","family":"Kumar","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Toxicology, National Institute of Pharmaceutical Education and Research (NIPER) , SAS Nagar, Punjab 160062 ,","place":["India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3722-991X","authenticated-orcid":false,"given":"Poonam","family":"Negi","sequence":"additional","affiliation":[{"name":"Amity Institute of Pharmacy, Amity University , Mohali, Punjab 140306 ,","place":["India"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,9,12]]},"reference":[{"key":"2026091212423599800_ref1","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.iac.2010.06.003","article-title":"Epidemiology of atopic dermatitis and atopic march in children","volume":"30","author":"Spergel","year":"2010","journal-title":"Immunol Allergy Clin N Am"},{"key":"2026091212423599800_ref2","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1111\/all.13401","article-title":"Epidemiology of atopic dermatitis in adults: results from an international survey","volume":"73","author":"Barbarot","year":"2018","journal-title":"Allergy"},{"key":"2026091212423599800_ref3","doi-asserted-by":"publisher","first-page":"2469646","DOI":"10.1080\/09546634.2025.2469646","article-title":"Evaluating the necessity of formal atopic dermatitis severity measurement tools in clinical practice","volume":"36","author":"Buttar","year":"2025","journal-title":"J Dermatolog Treat"},{"key":"2026091212423599800_ref4","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/978-3-319-64804-0_4","article-title":"Clinical presentation of atopic dermatitis","volume":"1027","author":"Ahn","year":"2017","journal-title":"Adv Exp Med Biol"},{"key":"2026091212423599800_ref5","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.jaci.2006.02.031","article-title":"Patient perspectives on the management of atopic dermatitis","volume":"118","author":"Zuberbier","year":"2006","journal-title":"J Allergy Clin Immunol"},{"key":"2026091212423599800_ref6","first-page":"81","volume-title":"Pathophysiology of Atopic Dermatitis","author":"Sarkar","year":"2025"},{"key":"2026091212423599800_ref7","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/s43556-025-00313-3","article-title":"Atopic dermatitis: diagnosis, molecular pathogenesis, and therapeutics","volume":"6","author":"Bai","year":"2025","journal-title":"Mol Biomed"},{"key":"2026091212423599800_ref8","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1016\/j.jaci.2008.01.022","article-title":"Basis for the barrier abnormality in atopic dermatitis: outside-inside-outside pathogenic mechanisms","volume":"121","author":"Elias","year":"2008","journal-title":"J Allergy Clin Immunol"},{"key":"2026091212423599800_ref9","doi-asserted-by":"publisher","first-page":"e33","DOI":"10.4110\/in.2024.24.e33","article-title":"Th pathways in immune-mediated skin disorders: a guide for strategic treatment decisions","volume":"24","author":"Speeckaert","year":"2024","journal-title":"Immune Netw"},{"key":"2026091212423599800_ref10","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1038\/ng1767","article-title":"Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis","volume":"38","author":"Palmer","year":"2006","journal-title":"Nat Genet"},{"key":"2026091212423599800_ref11","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1111\/bjd.16691","article-title":"Early-life regional and temporal variation in filaggrin-derived natural moisturizing factor, filaggrin-processing enzyme activity, corneocyte phenotypes and plasmin activity: implications for atopic dermatitis","volume":"179","author":"McAleer","year":"2018","journal-title":"Br J Dermatol"},{"key":"2026091212423599800_ref12","doi-asserted-by":"publisher","first-page":"adv00163","DOI":"10.2340\/00015555-3513","article-title":"Genetics in atopic dermatitis: historical perspective and future prospects","volume":"100","author":"Brown","year":"2020","journal-title":"Acta Derm Venereol"},{"key":"2026091212423599800_ref13","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1111\/j.0022-202X.2004.23547.x","article-title":"A proteolytic cascade of kallikreins in the stratum corneum","volume":"124","author":"Brattsand","year":"2005","journal-title":"J Invest Dermatol"},{"key":"2026091212423599800_ref14","first-page":"95","article-title":"The role of impaired epidermal barrier function in atopic dermatitis","volume":"24","author":"Jurakic Toncic","year":"2016","journal-title":"Acta Dermatovenerol Croat"},{"key":"2026091212423599800_ref15","doi-asserted-by":"crossref","first-page":"1335551","DOI":"10.3389\/fmed.2024.1335551","article-title":"Skin barrier-inflammatory pathway is a driver of the psoriasis-atopic dermatitis transition","volume":"11","author":"Dong","year":"2024","journal-title":"Front Med"},{"key":"2026091212423599800_ref16","doi-asserted-by":"publisher","first-page":"R7","DOI":"10.1016\/j.jaci.2009.07.012","article-title":"Cytokine modulation of atopic dermatitis filaggrin skin expression","volume":"124","author":"Howell","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"2026091212423599800_ref17","doi-asserted-by":"publisher","first-page":"2248","DOI":"10.1038\/jid.2008.74","article-title":"Th2 cytokines act on S100\/A11 to downregulate keratinocyte differentiation","volume":"128","author":"Howell","year":"2008","journal-title":"J Invest Dermatol"},{"key":"2026091212423599800_ref18","doi-asserted-by":"publisher","first-page":"1683","DOI":"10.3390\/cells11101683","article-title":"Keratinocytes: an enigmatic factor in atopic dermatitis","volume":"11","author":"Das","year":"2022","journal-title":"Cells"},{"key":"2026091212423599800_ref19","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1111\/j.1600-0625.2009.00899.x","article-title":"Induction of eosinophil- and Th2-attracting epidermal chemokines and cutaneous late-phase reaction in tape-stripped skin","volume":"18","author":"Onoue","year":"2009","journal-title":"Exp Dermatol"},{"key":"2026091212423599800_ref20","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.jaci.2006.03.037","article-title":"The genetics of atopic dermatitis","volume":"118","author":"Morar","year":"2006","journal-title":"J Allergy Clin Immunol"},{"key":"2026091212423599800_ref21","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22084130","article-title":"Molecular mechanisms of atopic dermatitis pathogenesis","author":"Sroka-Tomaszewska","year":"2021","journal-title":"Int J Mol Sci"},{"key":"2026091212423599800_ref22","doi-asserted-by":"publisher","first-page":"1406","DOI":"10.1016\/j.jaci.2019.11.047","article-title":"Progression of acute-to-chronic atopic dermatitis is associated with quantitative rather than qualitative changes in cytokine responses","volume":"145","author":"Tsoi","year":"2020","journal-title":"J Allergy Clin Immunol"},{"key":"2026091212423599800_ref23","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1016\/j.jaci.2016.06.010","article-title":"Cellular and molecular immunologic mechanisms in patients with atopic dermatitis","volume":"138","author":"Werfel","year":"2016","journal-title":"J Allergy Clin Immunol"},{"key":"2026091212423599800_ref24","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1111\/bjd.16934","article-title":"Atopic dermatitis: the skin barrier and beyond","volume":"180","author":"Tsakok","year":"2019","journal-title":"Br J Dermatol"},{"key":"2026091212423599800_ref25","doi-asserted-by":"publisher","first-page":"54073","DOI":"10.12775\/qs.2024.19.54073","article-title":"Understanding the pathophysiology of atopic dermatitis \u2013 insights into immune dysregulation and skin barrier dysfunction","volume":"19","author":"Kucharska","year":"2024","journal-title":"Qual Sport"},{"key":"2026091212423599800_ref26","doi-asserted-by":"publisher","DOI":"10.3390\/jcm14020598","article-title":"The role of TSLP and IL-1 beta and Their genetic variants in the pathogenesis of single and multiple atopic diseases in children","volume":"14","author":"Sikorska-Szaflik","year":"2025","journal-title":"J Clin Med"},{"key":"2026091212423599800_ref27","doi-asserted-by":"publisher","first-page":"52","DOI":"10.3389\/fcimb.2012.00052","article-title":"Staphylococcal superantigens in colonization and disease","volume":"2","author":"Xu","year":"2012","journal-title":"Front Cell Infect Microbiol"},{"key":"2026091212423599800_ref28","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/j.jaci.2005.10.033","article-title":"IL-31: a new link between T cells and pruritus in atopic skin inflammation","volume":"117","author":"Sonkoly","year":"2006","journal-title":"J Allergy Clin Immunol"},{"key":"2026091212423599800_ref29","doi-asserted-by":"crossref","first-page":"593","DOI":"10.4168\/aair.2019.11.5.593","article-title":"Interactions between atopic dermatitis and Staphylococcus aureus infection: clinical implications","volume":"11","author":"Kim","year":"2019","journal-title":"Allergy, Asthma Immunol Res"},{"key":"2026091212423599800_ref30","doi-asserted-by":"publisher","first-page":"23180","DOI":"10.1038\/s41598-025-05667-w","article-title":"Monolaurin inhibits antibiotic-resistant Staphylococcus aureus in patients with atopic dermatitis","volume":"15","author":"Laowansiri","year":"2025","journal-title":"Sci Rep"},{"key":"2026091212423599800_ref31","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1542\/pir.2024-006587","article-title":"Atopic dermatitis part 2: management","volume":"46","author":"Pennal","year":"2025","journal-title":"Pediatr Rev"},{"key":"2026091212423599800_ref32","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1016\/S0140-6736(19)33174-5","article-title":"Emollients for prevention of atopic dermatitis in infancy","volume":"395","author":"Perrett","year":"2020","journal-title":"Lancet"},{"key":"2026091212423599800_ref33"},{"key":"2026091212423599800_ref34","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1186\/s12903-025-06120-0","article-title":"Comparing the efficacy of topical interventions for pain management in oral lichen planus: a time-stratified bayesian network analysis of randomized controlled trials","volume":"25","author":"Zhang","year":"2025","journal-title":"BMC Oral Health"},{"key":"2026091212423599800_ref35","doi-asserted-by":"publisher","first-page":"91","DOI":"10.3390\/pharmaceutics17010091","article-title":"Exploring the therapeutic landscape: a narrative review on topical and Oral Phosphodiesterase-4 inhibitors in dermatology","volume":"17","author":"Carmona-Rocha","year":"2025","journal-title":"Pharmaceutics"},{"key":"2026091212423599800_ref36","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1007\/s40629-025-00346-8","article-title":"Update on conventional therapy for atopic dermatitis","volume":"34","author":"Perzynski","year":"2025","journal-title":"Allergo J Int"},{"key":"2026091212423599800_ref37","doi-asserted-by":"crossref","first-page":"1","DOI":"10.25259\/IJSA_9_2025","article-title":"Cyclosporine in dermatology: evidence-based review with a special focus on recent updates","volume":"4","author":"Dutta","year":"2025","journal-title":"Indian J Ski Allergy"},{"key":"2026091212423599800_ref38","doi-asserted-by":"publisher","first-page":"5053","DOI":"10.3390\/jcm14145053","article-title":"Anti-inflammatory therapies for atopic dermatitis: a new era in targeted treatment","volume":"14","author":"Bilinski","year":"2025","journal-title":"J Clin Med"},{"key":"2026091212423599800_ref39","doi-asserted-by":"publisher","volume":"14","DOI":"10.7573\/dic.2025-7-10"},{"key":"2026091212423599800_ref40"},{"key":"2026091212423599800_ref41","doi-asserted-by":"publisher","first-page":"e133","DOI":"10.1002\/ski2.133","article-title":"Oral Janus kinase inhibitors in the treatment of atopic dermatitis: a systematic review and meta-analysis","volume":"3","author":"Lee","year":"2023","journal-title":"Skin Health Dis"},{"key":"2026091212423599800_ref42","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1016\/j.jaci.2021.08.009","article-title":"JAK inhibitors in the treatment of atopic dermatitis","volume":"148","author":"Chovatiya","year":"2021","journal-title":"J Allergy Clin Immunol"},{"key":"2026091212423599800_ref43","doi-asserted-by":"publisher","first-page":"S24","DOI":"10.1089\/derm.2023.0058","article-title":"Efficacy and risk stratification of Janus kinase inhibitors in the treatment of moderate-to-severe atopic dermatitis","volume":"35","author":"Narla","year":"2024","journal-title":"Dermatitis"},{"key":"2026091212423599800_ref44","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1111\/all.16009","article-title":"Treatment of atopic dermatitis: recently approved drugs and advanced clinical development programs","volume":"79","author":"M\u00fcller","year":"2024","journal-title":"Allergy"},{"key":"2026091212423599800_ref45","doi-asserted-by":"publisher","first-page":"416","DOI":"10.4103\/2229-5178.142483","article-title":"Side-effects of topical steroids: a long overdue revisit","volume":"5","author":"Coondoo","year":"2014","journal-title":"Indian Dermatol Online J"},{"key":"2026091212423599800_ref46","doi-asserted-by":"publisher","first-page":"1","DOI":"10.5414\/alx01285e","article-title":"Systemic therapy of atopic dermatitis","volume":"1","author":"Bu\u00dfmann","year":"2017","journal-title":"Allergol Select"},{"key":"2026091212423599800_ref47","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1111\/ddg.15688","article-title":"Atopic dermatitis relapse after treatment discontinuation and predictive factors for relapse: JAK1 inhibitors versus dupilumab","volume":"23","author":"Wu","year":"2025","journal-title":"J Dtsch Dermatol Ges"},{"key":"2026091212423599800_ref48","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1111\/all.70187","article-title":"Drug survival in atopic dermatitis: comparison of biologics and JAK inhibitors in the BioDay registry","volume":"81","author":"Gang","year":"2026","journal-title":"Allergy"},{"key":"2026091212423599800_ref49","doi-asserted-by":"publisher","first-page":"5659","DOI":"10.3390\/ijms20225659","article-title":"Trends in atopic dermatitis-from standard pharmacotherapy to novel drug delivery systems","volume":"20","author":"Souto","year":"2019","journal-title":"Int J Mol Sci"},{"key":"2026091212423599800_ref50","doi-asserted-by":"publisher","first-page":"e202400968","DOI":"10.1002\/cbic.202400968","article-title":"Advances in drug delivery Systems for Atopic Dermatitis Treatment","volume":"26","author":"Yang","year":"2025","journal-title":"Chembiochem"},{"key":"2026091212423599800_ref51","doi-asserted-by":"publisher","journal-title":"Pharm Nanotechnol","DOI":"10.2174\/0122117385373434250705125526"},{"key":"2026091212423599800_ref52","doi-asserted-by":"publisher","first-page":"3271","DOI":"10.2147\/DDDT.S264648","article-title":"Potential of nanoparticles as permeation enhancers and targeted delivery options for skin: advantages and disadvantages","volume":"14","author":"Ghasemiyeh","year":"2020","journal-title":"Drug Des Dev Ther"},{"key":"2026091212423599800_ref53","doi-asserted-by":"publisher","volume":"3","DOI":"10.2174\/012210299X358884250211064638"},{"key":"2026091212423599800_ref54","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1186\/1556-276X-8-102","article-title":"Liposome: classification, preparation, and applications","volume":"8","author":"Akbarzadeh","year":"2013","journal-title":"Nanoscale Res Lett"},{"key":"2026091212423599800_ref55","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.3390\/pharmaceutics16121525","article-title":"Innovative approaches to enhancing the biomedical properties of liposomes","volume":"16","author":"Dejeu","year":"2024","journal-title":"Pharmaceutics"},{"key":"2026091212423599800_ref56","doi-asserted-by":"crossref","first-page":"245","DOI":"10.3390\/gels11040245","article-title":"Insights into liposomal and gel-based formulations for dermatological treatments","volume":"11","author":"Strazzabosco","year":"2025","journal-title":"Gels"},{"key":"2026091212423599800_ref57","doi-asserted-by":"publisher","first-page":"286","DOI":"10.3389\/fphar.2015.00286","article-title":"Advances and challenges of liposome assisted drug delivery","volume":"6","author":"Sercombe","year":"2015","journal-title":"Front Pharmacol"},{"key":"2026091212423599800_ref58","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1248\/bpb.b19-00259","article-title":"Anti-RelA siRNA-encapsulated flexible liposome with tight junction-opening peptide as a non-invasive topical therapeutic for atopic dermatitis","volume":"42","author":"Ibaraki","year":"2019","journal-title":"Biol Pharm Bull"},{"key":"2026091212423599800_ref59","doi-asserted-by":"publisher","first-page":"1566","DOI":"10.3390\/molecules29071566","article-title":"Evaluation of antioxidant activity and treatment of eczema by Berberine hydrochloride-loaded liposomes-in-gel","volume":"29","author":"Shen","year":"2024","journal-title":"Molecules"},{"key":"2026091212423599800_ref60","doi-asserted-by":"publisher","first-page":"2459","DOI":"10.2147\/IJN.S24350","article-title":"Tat peptide-admixed elastic liposomal formulation of hirsutenone for the treatment of atopic dermatitis in NC\/Nga mice","volume":"6","author":"Kang","year":"2011","journal-title":"Int J Nanomedicine"},{"key":"2026091212423599800_ref61","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1002\/jgm.1268","article-title":"Topical delivery of interleukin-13 antisense oligonucleotides with cationic elastic liposome for the treatment of atopic dermatitis","volume":"11","author":"Kim","year":"2009","journal-title":"J Gene Med"},{"key":"2026091212423599800_ref62","doi-asserted-by":"publisher","first-page":"565285","DOI":"10.3389\/fimmu.2020.565285","article-title":"Improved anti-inflammatory effects of liposomal Astaxanthin on a phthalic anhydride-induced atopic dermatitis model","volume":"11","author":"Lee","year":"2020","journal-title":"Front Immunol"},{"key":"2026091212423599800_ref63","doi-asserted-by":"publisher","first-page":"122045","DOI":"10.1016\/j.ijpharm.2022.122045","article-title":"Liposomes encapsulating novel antimicrobial peptide Omiganan: characterization and its pharmacodynamic evaluation in atopic dermatitis and psoriasis mice model","volume":"624","author":"Javia","year":"2022","journal-title":"Int J Pharm"},{"key":"2026091212423599800_ref64","doi-asserted-by":"publisher","DOI":"10.3390\/gels9030198","volume":"9","year":"2023","journal-title":"Gels"},{"key":"2026091212423599800_ref65","doi-asserted-by":"publisher","first-page":"106680","DOI":"10.1016\/j.ejps.2023.106680","article-title":"Tetramethylpyrazine-loaded liposomes surrounded by hydrogel based on sodium alginate and chitosan as a multifunctional drug delivery system for treatment of atopic dermatitis","volume":"193","author":"Xia","year":"2024","journal-title":"Eur J Pharm Sci"},{"key":"2026091212423599800_ref66","doi-asserted-by":"publisher","first-page":"7676","DOI":"10.3390\/ijms25147676","article-title":"Antioxidant activity and the therapeutic effect of Sinomenine hydrochloride-loaded liposomes-in-hydrogel on atopic dermatitis","volume":"25","author":"Chen","year":"2024","journal-title":"Int J Mol Sci"},{"key":"2026091212423599800_ref67","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1080\/03639045.2025.2467857","article-title":"Development and characterization of a Vaccinium vitis-idaea liposomal gel for the treatment of atopic dermatitis","volume":"51","author":"Zhang","year":"2025","journal-title":"Drug Dev Ind Pharm"},{"key":"2026091212423599800_ref68","doi-asserted-by":"publisher","DOI":"10.1002\/wnan.1918"},{"key":"2026091212423599800_ref69","doi-asserted-by":"publisher","first-page":"114535","DOI":"10.1016\/j.ejpb.2024.114535","article-title":"Development of transferosomes for topical ocular drug delivery of curcumin","volume":"205","author":"Barbalho","year":"2024","journal-title":"Eur J Pharm Biopharm"},{"key":"2026091212423599800_ref70","doi-asserted-by":"publisher","first-page":"303","DOI":"10.3390\/gels9040303","article-title":"DOE-assisted formulation, optimization, and characterization of tioconazole-loaded transferosomal hydrogel for the effective treatment of atopic dermatitis: in vitro and in vivo evaluation","volume":"9","author":"Kharwade","year":"2023","journal-title":"Gels"},{"key":"2026091212423599800_ref71","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1016\/j.ajps.2013.09.005","article-title":"Development of tacrolimus-loaded transfersomes for deeper skin penetration enhancement and therapeutic effect improvement in vivo","volume":"8","author":"Lei","year":"2013","journal-title":"Asian J Pharm Sci"},{"key":"2026091212423599800_ref72","doi-asserted-by":"publisher","volume":"9","DOI":"10.3390\/gels9040303"},{"key":"2026091212423599800_ref73","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1016\/j.xphs.2023.10.033","article-title":"Development and evaluation of tacrolimus loaded Nano-Transferosomes for skin targeting and dermatitis treatment","volume":"113","author":"Ren","year":"2024","journal-title":"J Pharm Sci"},{"key":"2026091212423599800_ref74","doi-asserted-by":"publisher","first-page":"2356","DOI":"10.1080\/09205063.2023.2247879","article-title":"Design, optimization, and characterization of Althaea officinalis-loaded transliposomes for the treatment of atopic dermatitis: a box Behnken design, in vitro, and ex vivo study","volume":"34","author":"Albratty","year":"2023","journal-title":"J Biomater Sci Polym Ed"},{"key":"2026091212423599800_ref75","first-page":"81","article-title":"Fighting pancreatic cancer: from bench to bedside using solid lipid nanoparticle","volume":"4","author":"Tiwari","year":"2012","journal-title":"Indian Res J Genet Biotechnol"},{"key":"2026091212423599800_ref76","doi-asserted-by":"publisher","first-page":"509","DOI":"10.18433\/jpps31788","article-title":"Solid lipid nanoparticles: an approach to improve oral drug delivery","volume":"24","author":"Mendoza-Munoz","year":"2021","journal-title":"J Pharm Pharm Sci"},{"key":"2026091212423599800_ref77","doi-asserted-by":"publisher","first-page":"138","DOI":"10.2174\/2211738511666221026163303","article-title":"Solid lipid nanoparticles (SLNs): advancements in modification strategies toward drug delivery vehicle","volume":"11","author":"Al-Sayadi","year":"2023","journal-title":"Pharm Nanotechnol"},{"key":"2026091212423599800_ref78","doi-asserted-by":"publisher","first-page":"5056","DOI":"10.1038\/s41467-022-32804-0","article-title":"In-situ growth of robust superlubricated nano-skin on electrospun nanofibers for post-operative adhesion prevention","volume":"13","author":"Wang","year":"2022","journal-title":"Nat Commun"},{"key":"2026091212423599800_ref79","doi-asserted-by":"crossref","first-page":"510","DOI":"10.31083\/ph.2009.8373","article-title":"Topical administration of cyclosporin a in a solid lipid nanoparticle formulation","volume":"64","author":"Kim","year":"2009","journal-title":"Pharmazie"},{"key":"2026091212423599800_ref80","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.jclepro.2019.02.270","article-title":"Conversion of organic resources by black soldier fly larvae: legislation, efficiency and environmental impact","volume":"222","author":"Bosch","year":"2019","journal-title":"J Clean Prod"},{"key":"2026091212423599800_ref81","doi-asserted-by":"publisher","first-page":"124929","DOI":"10.1016\/j.ijpharm.2024.124929","article-title":"Lipid extract from black soldier Fly larvae: a high value excipient for solid lipid nanoparticles tailored to tackle atopic dermatitis","volume":"667","author":"Almeida","year":"2024","journal-title":"Int J Pharm"},{"key":"2026091212423599800_ref82","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1208\/s12249-024-02785-y","article-title":"Eugenol-loaded Transethosomal gel for improved skin delivery and treatment of atopic dermatitis","volume":"25","author":"Kashyap","year":"2024","journal-title":"AAPS PharmSciTech"},{"key":"2026091212423599800_ref83","doi-asserted-by":"publisher","first-page":"103876","DOI":"10.1016\/j.xphs.2025.103876","article-title":"Sustained release of betamethasone from solid lipid nanoparticles loaded polymeric hydrogels with natural emollient: one step closer to effective topical therapy for atopic dermatitis","volume":"114","author":"Athavale","year":"2025","journal-title":"J Pharm Sci"},{"key":"2026091212423599800_ref84","doi-asserted-by":"publisher","first-page":"103365","DOI":"10.1016\/j.jddst.2022.103365","article-title":"Nanostructured lipid carrier based dermal gel of cyclosporine for atopic dermatitis-in vitro and in vivo evaluation","volume":"72","author":"Wairkar","year":"2022","journal-title":"J Drug Delivery Sci Technol"},{"key":"2026091212423599800_ref85","doi-asserted-by":"publisher","first-page":"5382","DOI":"10.2174\/1381612822666160726123227","article-title":"Cubic phases, cubosomes and ethosomes for cutaneous application","volume":"22","author":"Esposito","year":"2016","journal-title":"Curr Pharm Des"},{"key":"2026091212423599800_ref86","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1248\/bpb.30.350","article-title":"Cubosomes: an overview","volume":"30","author":"Garg","year":"2007","journal-title":"Biol Pharm Bull"},{"key":"2026091212423599800_ref87","doi-asserted-by":"publisher","first-page":"13388","DOI":"10.1021\/ja026085g","article-title":"Polymerized bicontinuous cubic nanoparticles (cubosomes) from a reactive monoacylglycerol","volume":"124","author":"Yang","year":"2002","journal-title":"J Am Chem Soc"},{"key":"2026091212423599800_ref88","doi-asserted-by":"crossref","first-page":"118","DOI":"10.9734\/jpri\/2021\/v33i31B31698","article-title":"Cubosomes as potential nanocarrier for drug delivery: a comprehensive review","volume":"33","author":"Kaur","year":"2021","journal-title":"J Pharm Res Int"},{"key":"2026091212423599800_ref89","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1002\/cnma.201900468","article-title":"Pep-lipid Cubosomes and vesicles compartmentalized by micelles from self-assembly of multiple neuroprotective building blocks including a large peptide hormone PACAP-DHA","volume":"5","author":"Angelova","year":"2019","journal-title":"ChemNanoMat"},{"key":"2026091212423599800_ref90","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.3109\/03639045.2013.819883","article-title":"In vitro skin permeation and anti-atopic efficacy of lipid nanocarriers containing water soluble extracts of Houttuynia cordata","volume":"40","author":"Kwon","year":"2014","journal-title":"Drug Dev Ind Pharm"},{"key":"2026091212423599800_ref91","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1111\/jocd.14685","article-title":"Emerging topical drug delivery approaches for the treatment of atopic dermatitis","volume":"21","author":"Ghosalkar","year":"2022","journal-title":"J Cosmet Dermatol"},{"key":"2026091212423599800_ref92","doi-asserted-by":"crossref","first-page":"64","DOI":"10.3390\/pharmaceutics13010064","article-title":"Chronic inflammatory diseases, anti-inflammatory agents and their delivery nanosystems","volume":"13","author":"Placha","year":"2021","journal-title":"Pharmaceutics"},{"key":"2026091212423599800_ref93","doi-asserted-by":"publisher","first-page":"129","DOI":"10.2147\/IJN.S150319","article-title":"Tacrolimus nanoparticles based on chitosan combined with nicotinamide: enhancing percutaneous delivery and treatment efficacy for atopic dermatitis and reducing dose","volume":"13","author":"Yu","year":"2018","journal-title":"Int J Nanomedicine"},{"key":"2026091212423599800_ref94","doi-asserted-by":"crossref","first-page":"82","DOI":"10.3390\/jfb14020082","article-title":"Hyaluronic acid hydrogel containing resveratrol-loaded chitosan nanoparticles as an adjuvant in atopic dermatitis treatment","volume":"14","author":"Conte","year":"2023","journal-title":"J Funct Biomater"},{"key":"2026091212423599800_ref95","doi-asserted-by":"publisher","first-page":"8779","DOI":"10.2147\/IJN.S472999","article-title":"Molybdenum nanoparticles alleviate MC903-induced atopic dermatitis-like symptoms in mice by modulating the ROS-mediated NF-kappaB and Nrf2 \/HO-1 Signaling pathways","volume":"19","author":"Xiao","year":"2024","journal-title":"Int J Nanomedicine"},{"key":"2026091212423599800_ref96","doi-asserted-by":"publisher","DOI":"10.3390\/nano12040636","article-title":"Tetrahydrocurcumin lipid nanoparticle based gel promotes penetration into deeper skin layers and alleviates atopic dermatitis in 2,4-dinitrochlorobenzene (DNCB) mouse model","volume":"12","author":"Saini","year":"2022","journal-title":"Nanomaterials (Basel)"},{"key":"2026091212423599800_ref97","doi-asserted-by":"publisher","first-page":"e2204184","DOI":"10.1002\/advs.202204184","article-title":"Melittin-carrying nanoparticle suppress T cell-driven immunity in a murine allergic dermatitis model","volume":"10","author":"Liu","year":"2023","journal-title":"Adv Sci (Weinh)"},{"key":"2026091212423599800_ref98","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics15071927","article-title":"Polymeric nanoparticles' accumulation in atopic dermatitis: clinical comparison between healthy, non-Lesional, and Lesional skin","volume":"15","author":"Try","year":"2023","journal-title":"Pharmaceutics"},{"key":"2026091212423599800_ref99","doi-asserted-by":"publisher","first-page":"136984","DOI":"10.1016\/j.ijbiomac.2024.136984","article-title":"Differences in the permeation of Licoricchalcone A-polysaccharide self-assembled nanoparticles on healthy and DNCB-induced atopic dermatitis in Balb\/c mice","volume":"282","author":"Chen","year":"2024","journal-title":"Int J Biol Macromol"},{"key":"2026091212423599800_ref100","doi-asserted-by":"publisher","first-page":"133005","DOI":"10.1016\/j.ijbiomac.2024.133005","article-title":"Tacrolimus-loaded chitosan-based nanoparticles as an efficient topical therapeutic for the effective treatment of atopic dermatitis symptoms","volume":"273","author":"Lee","year":"2024","journal-title":"Int J Biol Macromol"},{"key":"2026091212423599800_ref101","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1016\/j.jconrel.2023.08.061","article-title":"Chitosan hydrogels with MK2 inhibitor peptide-loaded nanoparticles to treat atopic dermatitis","volume":"362","author":"Dartora","year":"2023","journal-title":"J Control Release"},{"key":"2026091212423599800_ref102","doi-asserted-by":"publisher","first-page":"10131","DOI":"10.1039\/d3tb01202f","article-title":"Development and application of novel peptide-formulated nanoparticles for treatment of atopic dermatitis","volume":"11","author":"Lim","year":"2023","journal-title":"J Mater Chem B"},{"key":"2026091212423599800_ref103","doi-asserted-by":"publisher","first-page":"112244","DOI":"10.1016\/j.colsurfb.2021.112244","article-title":"Immunomodulatory and anti-inflammatory efficacy of hederagenin-coated maghemite (gamma-Fe(2)O(3)) nanoparticles in an atopic dermatitis model","volume":"210","author":"Lee","year":"2022","journal-title":"Colloids Surf B Biointerfaces"},{"key":"2026091212423599800_ref104","doi-asserted-by":"publisher","first-page":"3235","DOI":"10.2147\/IJN.S509798","article-title":"Enhanced dermal delivery of Nanoparticulate formulation of Cutibacterium acnes using sponge spicules for atopic dermatitis treatment","volume":"20","author":"Jin","year":"2025","journal-title":"Int J Nanomedicine"},{"key":"2026091212423599800_ref105","doi-asserted-by":"publisher","DOI":"10.3390\/gels10010079","article-title":"Formulation of budesonide-loaded polymeric nanoparticles into hydrogels for local therapy of atopic dermatitis","volume":"10","author":"Slavkova","year":"2024","journal-title":"Gels"},{"key":"2026091212423599800_ref106","doi-asserted-by":"publisher","first-page":"121079","DOI":"10.1016\/j.ijpharm.2021.121079","article-title":"Tacrolimus encapsulated mesoporous silica nanoparticles embedded hydrogel for the treatment of atopic dermatitis","volume":"608","author":"Parekh","year":"2021","journal-title":"Int J Pharm"},{"key":"2026091212423599800_ref107","doi-asserted-by":"publisher","first-page":"710","DOI":"10.3109\/10837450.2012.712537","article-title":"Hydrocortisone-loaded poly(epsilon-caprolactone) nanoparticles for atopic dermatitis treatment","volume":"18","author":"Rosado","year":"2013","journal-title":"Pharm Dev Technol"},{"key":"2026091212423599800_ref108","doi-asserted-by":"publisher","first-page":"5143","DOI":"10.2147\/IJN.S71543","article-title":"Downregulation of immunological mediators in 2,4-dinitrofluorobenzene-induced atopic dermatitis-like skin lesions by hydrocortisone-loaded chitosan nanoparticles","volume":"9","author":"Hussain","year":"2014","journal-title":"Int J Nanomedicine"},{"key":"2026091212423599800_ref109","doi-asserted-by":"publisher","first-page":"124029","DOI":"10.1016\/j.ijpharm.2024.124029","article-title":"Development of a hydrogel containing bisabolol-loaded nanocapsules for the treatment of atopic dermatitis in a Balb\/c mice model","volume":"656","author":"Karami","year":"2024","journal-title":"Int J Pharm"},{"key":"2026091212423599800_ref110","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/1743-8977-9-3","article-title":"Amorphous silica nanoparticles size-dependently aggravate atopic dermatitis-like skin lesions following an intradermal injection","volume":"9","author":"Hirai","year":"2012","journal-title":"Part Fibre Toxicol"},{"key":"2026091212423599800_ref111","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1186\/s12951-023-02207-4","article-title":"Topical bismuth oxide-manganese composite nanospheres alleviate atopic dermatitis-like inflammation","volume":"21","author":"Li","year":"2023","journal-title":"J Nanobiotechnology"},{"key":"2026091212423599800_ref112","doi-asserted-by":"publisher","first-page":"134404","DOI":"10.1016\/j.ijbiomac.2024.134404","article-title":"Therapeutic effects of chamomile volatile oil nanoemulsion\/Bletilla striata polysaccharides gels on atopic dermatitis","volume":"277","author":"Xu","year":"2024","journal-title":"Int J Biol Macromol"},{"key":"2026091212423599800_ref113","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1080\/03639045.2023.2244075","article-title":"Crisaborole loaded nanoemulgel for the mitigation of atopic dermatitis in mice model","volume":"49","author":"Kataria","year":"2023","journal-title":"Drug Dev Ind Pharm"},{"key":"2026091212423599800_ref114","doi-asserted-by":"publisher","first-page":"277","DOI":"10.3390\/nano12020277","article-title":"Biomedical applications of metal-organic frameworks for disease diagnosis and drug delivery: a review","volume":"12","author":"Al Sharabati","year":"2022","journal-title":"Nanomaterials (Basel)"},{"key":"2026091212423599800_ref115","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1186\/s12951-023-01924-0","article-title":"Zn-MOF hydrogel: regulation of ROS-mediated inflammatory microenvironment for treatment of atopic dermatitis","volume":"21","author":"Qiu","year":"2023","journal-title":"J Nanobiotechnology"},{"key":"2026091212423599800_ref116","doi-asserted-by":"publisher","first-page":"214875","DOI":"10.1016\/j.bioadv.2026.214875","article-title":"Engineering fast-acting anti-itching multifunctional dressing with quercetin-CD-MOF for atopic dermatitis","volume":"185","author":"Li","year":"2026","journal-title":"Biomater Adv"},{"key":"2026091212423599800_ref117","doi-asserted-by":"publisher","first-page":"3186","DOI":"10.1021\/jacs.3c11059","article-title":"Dual-site biomimetic Cu\/Zn-MOF for atopic dermatitis catalytic therapy via suppressing FcgammaR-mediated phagocytosis","volume":"146","author":"Huang","year":"2024","journal-title":"J Am Chem Soc"},{"key":"2026091212423599800_ref118","doi-asserted-by":"publisher","first-page":"26386","DOI":"10.1021\/acsami.5c02334","article-title":"Separable microneedle patch integrated with the Dictamnine-loaded copper MOF Nanozyme for atopic dermatitis treatment","volume":"17","author":"Liu","year":"2025","journal-title":"ACS Appl Mater Interfaces"},{"key":"2026091212423599800_ref119","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1021\/acsnanomed.5c00046","article-title":"Nanocosmeceuticals for dermatological and aesthetic applications: bridging material innovation with clinical and regulatory translation","volume":"1","author":"Zhao","year":"2026","journal-title":"ACS Nano Medicine"},{"key":"2026091212423599800_ref120","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1007\/s11095-021-03053-5","article-title":"Ethosomes as nanocarriers for the development of skin delivery formulations","volume":"38","author":"Paiva-Santos","year":"2021","journal-title":"Pharm Res"},{"key":"2026091212423599800_ref121","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1517\/17425247.2013.860130","article-title":"Nanovesicular carriers as alternative drug delivery systems: Ethosomes in focus","volume":"11","author":"Mbah","year":"2014","journal-title":"Expert Opin Drug Del"},{"key":"2026091212423599800_ref122","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1080\/08982104.2021.1880436","article-title":"Topical creams of piperine loaded lipid nanocarriers for management of atopic dermatitis: development, characterization, and in vivo investigation using BALB\/c mice model","volume":"32","author":"Kumar","year":"2022","journal-title":"J Liposome Res"},{"key":"2026091212423599800_ref123","doi-asserted-by":"publisher","first-page":"874053","DOI":"10.1100\/2012\/874053","article-title":"Preparation and In vitro evaluation of tacrolimus-loaded ethosomes","volume":"2012","author":"Li","year":"2012","journal-title":"Sci World J"},{"key":"2026091212423599800_ref124","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.nantod.2012.01.002","article-title":"Polymeric micelle stability","volume":"7","author":"Owen","year":"2012","journal-title":"Nano Today"},{"key":"2026091212423599800_ref125","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/s0168-3659(01)00299-1","article-title":"Structure and design of polymeric surfactant-based drug delivery systems","volume":"73","author":"Torchilin","year":"2001","journal-title":"J Control Release"},{"key":"2026091212423599800_ref126","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.jconrel.2021.02.016","article-title":"Polymeric micelles in cancer therapy: state of the art","volume":"332","author":"Ghosh","year":"2021","journal-title":"J Control Release"},{"key":"2026091212423599800_ref127","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1021\/acs.molpharmaceut.4c00990","article-title":"Development of pluronic-based micelles from palm oil bioactive compounds incorporated by a dissolvable microarray patch to enhance the efficacy of atopic dermatitis therapy","volume":"22","author":"Jannah","year":"2025","journal-title":"Mol Pharm"},{"key":"2026091212423599800_ref128","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1208\/s12249-019-1355-6","article-title":"Optimization and evaluation of beclomethasone dipropionate micelles incorporated into biocompatible hydrogel using a sub-chronic dermatitis animal model","volume":"20","author":"Assem","year":"2019","journal-title":"AAPS PharmSciTech"},{"key":"2026091212423599800_ref129","doi-asserted-by":"publisher","first-page":"19145","DOI":"10.1021\/acsomega.2c08016","article-title":"New insights in topical drug delivery for skin disorders: from a nanotechnological perspective","volume":"8","author":"Raina","year":"2023","journal-title":"ACS Omega"},{"key":"2026091212423599800_ref130","doi-asserted-by":"publisher","first-page":"105395","DOI":"10.1016\/j.jddst.2024.105395","article-title":"Investigating the efficacy of mirtazapine-embedded invasomal gel nanocarriers via I-optimal design for management of atopic dermatitis","volume":"92","author":"Ibrahim","year":"2024","journal-title":"J Drug Delivery Sci Technol"},{"key":"2026091212423599800_ref131","doi-asserted-by":"publisher","first-page":"9851","DOI":"10.1007\/s00210-025-04002-4","article-title":"Novel drug delivery systems in topical treatment of atopic dermatitis","volume":"398","author":"Dabhadkar","year":"2025","journal-title":"Naunyn Schmiedeberg\u2019s Arch Pharmacol"},{"key":"2026091212423599800_ref132","doi-asserted-by":"publisher","first-page":"10433","DOI":"10.2147\/IJN.S548746","article-title":"The trilogy of skin regeneration via metal-organic frameworks Nanomedicine: precision Management of Refractory Wounds, pathological scarring, and hair follicle reactivation","volume":"20","author":"Lv","year":"2025","journal-title":"Int J Nanomedicine"},{"key":"2026091212423599800_ref133","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.coi.2017.08.010","article-title":"Revisiting murine models for atopic dermatitis and psoriasis with multipolar cytokine axes","volume":"48","author":"Kabashima","year":"2017","journal-title":"Curr Opin Immunol"},{"key":"2026091212423599800_ref134","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1208\/s12249-025-03244-y","article-title":"Progress and prospects of transdermal treatment of allergic skin diseases with natural drugs based on nanotechnology","volume":"27","author":"Lu","year":"2025","journal-title":"AAPS PharmSciTech"},{"key":"2026091212423599800_ref135","doi-asserted-by":"publisher","first-page":"1911","DOI":"10.1080\/17435889.2025.2533107","article-title":"Regulating nanomedicines: challenges, opportunities, and the path forward","volume":"20","author":"Mangla","year":"2025","journal-title":"Nanomedicine"},{"key":"2026091212423599800_ref136","doi-asserted-by":"publisher","first-page":"2096995","DOI":"10.1080\/19490976.2022.2096995","article-title":"Impact of gut microbiome on skin health: gut-skin axis observed through the lenses of therapeutics and skin diseases","volume":"14","author":"Mahmud","year":"2022","journal-title":"Gut Microbes"},{"key":"2026091212423599800_ref137","doi-asserted-by":"crossref","first-page":"868","DOI":"10.3390\/microorganisms13040868","article-title":"Skin microbiome overview: how physical activity influences bacteria","volume":"13","author":"Mennitti","year":"2025","journal-title":"Microorganisms [Internet]"},{"key":"2026091212423599800_ref138","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1126\/science.abo0693","article-title":"Microbiota and maintenance of skin barrier function","volume":"376","author":"Harris-Tryon","year":"2022","journal-title":"Science"},{"key":"2026091212423599800_ref139","doi-asserted-by":"crossref","first-page":"365","DOI":"10.3390\/ijms27010365","article-title":"From gut dysbiosis to skin inflammation in atopic dermatitis: probiotics and the gut\u2013skin axis\u2014clinical outcomes and microbiome implications","volume":"27","author":"Micu","year":"2026","journal-title":"Int J Mol Sci [Internet]"},{"key":"2026091212423599800_ref140","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1016\/j.jaad.2022.12.029","article-title":"Guidelines of care for the management of atopic dermatitis in adults with topical therapies","volume":"89","author":"Sidbury","year":"2023","journal-title":"J Am Acad Dermatol"},{"key":"2026091212423599800_ref141","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12175534","article-title":"Atopic dermatitis: beyond the skin and into the gut","volume":"12","author":"Sadowsky","year":"2023","journal-title":"J Clin Med"},{"key":"2026091212423599800_ref142","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1002\/mlf2.12064","article-title":"Human skin bacterial microbiota homeostasis: a delicate balance between health and disease","volume":"2","author":"Zhu","year":"2023","journal-title":"mLife"},{"key":"2026091212423599800_ref143","doi-asserted-by":"crossref","first-page":"2416","DOI":"10.3390\/microorganisms13112416","article-title":"Microbial interventions for inflammatory skin diseases: a systematic review and meta-analysis of atopic dermatitis and psoriasis","volume":"13","author":"Liscano","year":"2025","journal-title":"Microorganisms [Internet]"},{"key":"2026091212423599800_ref144","doi-asserted-by":"publisher","first-page":"210","DOI":"10.3892\/ijmm.2025.5651","article-title":"The gut-skin axis: emerging insights in understanding and treating skin diseases through gut microbiome modulation (review)","volume":"56","author":"Zhao","year":"2025","journal-title":"Int J Mol Med"},{"key":"2026091212423599800_ref145","doi-asserted-by":"publisher","first-page":"5026","DOI":"10.1007\/s12035-020-02073-3","article-title":"Gut microbiota and Dysbiosis in Alzheimer's disease: implications for pathogenesis and treatment","volume":"57","author":"Liu","year":"2020","journal-title":"Mol Neurobiol"},{"key":"2026091212423599800_ref146","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.brainres.2014.04.004","article-title":"Hygiene and other early childhood influences on the subsequent function of the immune system","volume":"1617","author":"Rook","year":"2015","journal-title":"Brain Res"},{"key":"2026091212423599800_ref147","doi-asserted-by":"publisher","first-page":"1613","DOI":"10.2147\/CCID.S442551","article-title":"Research Progress on the correlation of atopic dermatitis with gut microbiota","volume":"17","author":"Mao","year":"2024","journal-title":"Clin Cosmet Investig Dermatol"},{"key":"2026091212423599800_ref148","doi-asserted-by":"crossref","first-page":"e40193","DOI":"10.1097\/MD.0000000000040193","article-title":"Exploring the causal relationship between gut microbiota and atopic dermatitis: a Mendelian randomization study","volume":"103","author":"Li","year":"2024","journal-title":"Medicine"},{"key":"2026091212423599800_ref149","doi-asserted-by":"publisher","first-page":"2024","DOI":"10.3389\/fmicb.2024.1442126","article-title":"Changes in oral, skin, and gut microbiota in children with atopic dermatitis: a case-control study","volume":"Volume 15","author":"Zhang","year":"2024","journal-title":"Front Microbiol"},{"key":"2026091212423599800_ref150","doi-asserted-by":"publisher","first-page":"2450605","DOI":"10.1155\/2019\/2450605","article-title":"The role of the environmental risk factors in the pathogenesis and clinical outcome of atopic dermatitis","volume":"2019","author":"Bonamonte","year":"2019","journal-title":"Biomed Res Int"},{"key":"2026091212423599800_ref151","doi-asserted-by":"publisher","first-page":"6539","DOI":"10.3390\/ijms25126539","article-title":"The role of the microbiota in the pathogenesis and treatment of atopic dermatitis-a literature review","volume":"25","author":"Wrzesniewska","year":"2024","journal-title":"Int J Mol Sci"},{"key":"2026091212423599800_ref152","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.jpeds.2007.03.022","article-title":"Breast-feeding duration and infant atopic manifestations, by maternal allergic status, in the first 2 years of life (KOALA study)","volume":"151","author":"Snijders","year":"2007","journal-title":"J Pediatr"},{"key":"2026091212423599800_ref153","first-page":"1","article-title":"Progress and prospects of transdermal treatment of allergic skin diseases with natural drugs based on nanotechnology","volume":"27","author":"Lu","year":"2026","journal-title":"AAPS PharmSciTech"},{"key":"2026091212423599800_ref154","doi-asserted-by":"publisher","first-page":"2159","DOI":"10.1073\/pnas.0904055107","article-title":"Generation of regulatory dendritic cells and CD4+Foxp3+ T cells by probiotics administration suppresses immune disorders","volume":"107","author":"Kwon","year":"2010","journal-title":"Proc Natl Acad Sci USA"},{"key":"2026091212423599800_ref155","doi-asserted-by":"publisher","first-page":"116613","DOI":"10.1016\/j.jep.2023.116613","article-title":"Probiotic-fermented Portulaca oleracea L. alleviated DNFB-induced atopic dermatitis by inhibiting the NF-\u03baB signaling pathway","volume":"313","author":"Zhao","year":"2023","journal-title":"J Ethnopharmacol"},{"key":"2026091212423599800_ref156","doi-asserted-by":"publisher","first-page":"114687","DOI":"10.1016\/j.jep.2021.114687","article-title":"Effect of a combination of Korean red ginseng extract and probiotics on the prevention of atopic dermatitis in a murine model","volume":"283","author":"Lee","year":"2022","journal-title":"J Ethnopharmacol"},{"key":"2026091212423599800_ref157","doi-asserted-by":"publisher","first-page":"100649","DOI":"10.1016\/j.jacig.2026.100649","article-title":"Probiotics for pediatric atopic dermatitis: a systematic review and meta-analysis of randomized controlled trials","volume":"5","author":"Arif","year":"2026","journal-title":"J Allergy Clin Immunol Glob"},{"key":"2026091212423599800_ref158","doi-asserted-by":"publisher","first-page":"101304","DOI":"10.1016\/j.waojou.2026.101304","article-title":"The effect of topical probiotic lotion on atopic dermatitis in children","volume":"19","author":"Ahanchian","year":"2026","journal-title":"World Allergy Organ J"},{"key":"2026091212423599800_ref159","doi-asserted-by":"publisher","first-page":"823","DOI":"10.4014\/jmb.2301.01019","article-title":"Potential anti-allergy and immunomodulatory properties of Lactococcus lactis LB 1022 observed In vitro and in an atopic dermatitis mouse model","volume":"33","author":"Baek","year":"2023","journal-title":"J Microbiol Biotechnol"},{"key":"2026091212423599800_ref160","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.1111\/all.12700","article-title":"Probiotics for prevention of atopic diseases in infants: systematic review and meta-analysis","volume":"70","author":"Zuccotti","year":"2015","journal-title":"Allergy"},{"key":"2026091212423599800_ref161","doi-asserted-by":"publisher","first-page":"1498965","DOI":"10.3389\/fped.2025.1498965","article-title":"The impact of prebiotics, probiotics and synbiotics on the prevention and treatment of atopic dermatitis in children: an umbrella meta-analysis","volume":"13","author":"Wang","year":"2025","journal-title":"Front Pediatr"},{"key":"2026091212423599800_ref162","doi-asserted-by":"publisher","DOI":"10.1177\/17103568251367725","article-title":"Transforming atopic dermatitis management: probiotics as a game-changer in immune modulation\u2014a double-blind, placebo-controlled clinical trial","volume":"37","author":"Giorgio","journal-title":"Dermatitis"},{"key":"2026091212423599800_ref163","doi-asserted-by":"publisher","first-page":"1587348","DOI":"10.3389\/fnut.2025.1587348","article-title":"Probiotics supplements for the prevention of atopic dermatitis in children: an umbrella review","volume":"12","author":"Zhong","year":"2025","journal-title":"Front Nutr"},{"key":"2026091212423599800_ref164","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1007\/s00394-024-03524-6","article-title":"Frequent intake of high fiber and probiotic diets lowers risks associated with atopic dermatitis and house dust mite allergy: a cross-sequential study of young Chinese adults from Singapore and Malaysia","volume":"64","author":"Lim","year":"2025","journal-title":"Eur J Nutr"},{"key":"2026091212423599800_ref165","doi-asserted-by":"publisher","first-page":"673","DOI":"10.3390\/nu17040673","article-title":"Effect of supplementation with a specific probiotic (Bifidobacterium bifidum PRL2010) in pregnancy for the prevention of atopic dermatitis in children: preliminary results of a randomized trial","volume":"17","author":"Anania","year":"2025","journal-title":"Nutrients"},{"key":"2026091212423599800_ref166","doi-asserted-by":"publisher","first-page":"200332","DOI":"10.1016\/j.hnm.2025.200332","article-title":"The effect of probiotic (clostridium butyricum) on adult patients with atopic dermatitis: a retrospective cohort study from TriNetX","volume":"41","author":"Shu","year":"2025","journal-title":"Hum Nutr Metab"},{"key":"2026091212423599800_ref167","doi-asserted-by":"publisher","DOI":"10.12932\/AP-280323-1576","article-title":"Therapeutic effectiveness of probiotics for atopic dermatitis: a systematic review and meta-analysis of randomized controlled trials with subgroup analysis","volume":"43","author":"Kim","journal-title":"Asian Pac J Allergy Immunol"},{"key":"2026091212423599800_ref168","doi-asserted-by":"crossref","first-page":"5080190","DOI":"10.1155\/2022\/5080190","article-title":"Association of probiotics with atopic dermatitis among infant: a meta-analysis of randomized controlled trials","volume":"2022","author":"Pan","year":"2022","journal-title":"Oxidative Med Cell Longev"},{"key":"2026091212423599800_ref169","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1016\/j.adengl.2021.06.006","article-title":"Probiotics to reduce the severity of atopic dermatitis in pediatric patients: a systematic review and meta-analysis","volume":"112","author":"Pachacama L\u00f3pez","year":"2021","journal-title":"Actas Dermosifiliogr (Engl Ed)"},{"key":"2026091212423599800_ref170","doi-asserted-by":"publisher","first-page":"2800","DOI":"10.1080\/09546634.2022.2080170","article-title":"The efficacy of probiotics supplementation for the treatment of atopic dermatitis in adults: a systematic review and meta-analysis","volume":"33","author":"Li","year":"2022","journal-title":"J Dermatolog Treat"},{"key":"2026091212423599800_ref171","doi-asserted-by":"publisher","first-page":"1816","DOI":"10.3390\/foods14101816","article-title":"Therapeutic mechanism of kynurenine, a metabolite of probiotics, on atopic dermatitis in mice","volume":"14","author":"Li","year":"2025","journal-title":"Foods"},{"key":"2026091212423599800_ref172","doi-asserted-by":"publisher","first-page":"833666","DOI":"10.3389\/fnut.2021.833666","article-title":"Efficacy of probiotics in children and adolescents with atopic dermatitis: a randomized, double-blind, placebo-controlled study","volume":"8","author":"Andrade","year":"2021","journal-title":"Front Nutr"},{"key":"2026091212423599800_ref173","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1186\/s40001-022-00713-z","article-title":"The effect of probiotics on the clinical status of adult patients with atopic dermatitis: a systematic review","volume":"27","author":"Sodre","year":"2022","journal-title":"Eur J Med Res"},{"key":"2026091212423599800_ref174","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s41043-022-00318-6","article-title":"The role of probiotics in the treatment of adult atopic dermatitis: a meta-analysis of randomized controlled trials","volume":"41","author":"Umborowati","year":"2022","journal-title":"J Health Popul Nutr"},{"key":"2026091212423599800_ref175","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1007\/s43440-023-00510-3","article-title":"Challenges of current treatment and exploring the future prospects of nanoformulations for treatment of atopic dermatitis","volume":"75","author":"Kakkar","year":"2023","journal-title":"Pharmacol Rep"},{"key":"2026091212423599800_ref176","doi-asserted-by":"publisher","first-page":"397","DOI":"10.2174\/2211738511666230330115229","article-title":"Recent trends in Nanocarriers for the Management of Atopic Dermatitis","volume":"11","author":"Kumar","year":"2023","journal-title":"Pharm Nanotechnol"},{"key":"2026091212423599800_ref177","doi-asserted-by":"publisher","first-page":"114347","DOI":"10.1016\/j.jconrel.2025.114347","article-title":"A biocompatible tea polyphenol nanoplatform for efficient cytosolic delivery of protein therapeutics","volume":"388","author":"Wang","year":"2025","journal-title":"J Control Release"},{"key":"2026091212423599800_ref178","doi-asserted-by":"publisher","first-page":"113664","DOI":"10.1016\/j.jconrel.2025.113664","article-title":"Transdermal psoriasis treatment inspired by tumor microenvironment-mediated immunomodulation and advanced by exosomal engineering","volume":"382","author":"Yang","year":"2025","journal-title":"J Control Release"},{"key":"2026091212423599800_ref179","doi-asserted-by":"publisher","first-page":"5837","DOI":"10.2147\/IJN.S466042","article-title":"Tumor cell-targeting and tumor microenvironment\u2013responsive Nanoplatforms for the multimodal imaging-guided photodynamic\/Photothermal\/Chemodynamic treatment of cervical cancer","volume":"19","author":"Wang","year":"2024","journal-title":"Int J Nanomedicine"},{"key":"2026091212423599800_ref180","doi-asserted-by":"publisher","first-page":"313","DOI":"10.3390\/bios13030313","article-title":"Epidermal wearable biosensors for monitoring biomarkers of chronic disease in sweat","volume":"13","author":"Yuan","year":"2023","journal-title":"Biosensors (Basel)"},{"key":"2026091212423599800_ref181","doi-asserted-by":"crossref","first-page":"1322205","DOI":"10.3389\/fphys.2024.1322205","article-title":"Interaction between the microbiota and the skin barrier in aging skin: a comprehensive review","volume":"15","author":"Woo","year":"2024","journal-title":"Front Physiol"},{"key":"2026091212423599800_ref182","doi-asserted-by":"crossref","first-page":"425","DOI":"10.3390\/cells13050425","article-title":"Unraveling atopic dermatitis: insights into pathophysiology, therapeutic advances, and future perspectives","volume":"13","author":"Pareek","year":"2024","journal-title":"Cells"}],"container-title":["Journal of Pharmacy and Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jpp\/article-pdf\/78\/9\/rgag100\/71047147\/rgag100.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jpp\/article-pdf\/78\/9\/rgag100\/71047147\/rgag100.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T16:42:48Z","timestamp":1789231368000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jpp\/article\/doi\/10.1093\/jpp\/rgag100\/8793013"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,1]]},"references-count":182,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9,1]]}},"URL":"https:\/\/doi.org\/10.1093\/jpp\/rgag100","relation":{},"ISSN":["2042-7158"],"issn-type":[{"value":"2042-7158","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,9]]},"published":{"date-parts":[[2026,9,1]]},"article-number":"rgag100"}}